fully consider the clear and undeniably positive difference that PTABhas made, and as a signature element of the America Invents Act, it should not be ignored or cast aside
Support preserving and fully considering the Patent Trial and Appeal Board as an important mechanism for faster, cheaper patent-validity adjudication.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
Issa said PTAB is an important check for faster, cheaper patent-validity adjudication and urged the USPTO director to fully consider it rather than ignore or cast it aside.
legacy_unverified · Source version not recorded · locator unknown
Issa endorsed PTAB as an important check for faster, cheaper patent-validity adjudication and urged USPTO Director John Squires to fully consider it rather than cast it aside.
legacy_unverified · Source version not recorded · locator unknown
The House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet held a March 25, 2026 USPTO oversight hearing examining the agency's mission, operations, policies, and related matters.
Assessments
Issa personally and publicly endorsed PTAB as a faster, cheaper patent-validity adjudication mechanism and urged the USPTO director during his current House term to fully consider and use it rather than cast it aside. Because the promise was to support preservation and consideration, not to enact a statutory change, this official same-term advocacy and oversight activity satisfies the commitment.
The promise is framed as support for preserving and seriously considering the Patent Trial and Appeal Board, not as a requirement to single-handedly enact a final institutional outcome. The cited March 26, 2026 statement shows Darrell Issa publicly argued that PTAB is an important mechanism for faster, cheaper patent-validity review and urged the USPTO director to fully consider and utilize it rather than discard it. That is a direct fulfillment of a support/oversight-style promise during his current federal service, so this counts as delivered in the same term.
Issa publicly endorsed preserving and fully considering the PTAB as a useful, faster and cheaper patent-validity mechanism, which matches the claim. The evidence is a direct statement during his current term, so the promise is satisfied with same-term timing.